key: cord-0882738-pra0398r authors: Fernández‐Oliva, Alberto; Ortega‐González, Paula; Risco, Cristina title: Targeting host lipid flows: Exploring new antiviral and antibiotic strategies date: 2019-01-17 journal: Cell Microbiol DOI: 10.1111/cmi.12996 sha: ae2b25d3dc787647ea4ff6e49e3e559c5651ad6c doc_id: 882738 cord_uid: pra0398r Bacteria and viruses pose serious challenges for humans because they evolve continuously. Despite ongoing efforts, antiviral drugs to treat many of the most troubling viruses have not been approved yet. The recent launch of new antimicrobials is generating hope as more and more pathogens around the world become resistant to available drugs. But extra effort is still needed. One of the current strategies for antiviral and antibiotic drug development is the search for host cellular pathways used by many different pathogens. For example, many viruses and bacteria alter lipid synthesis and transport to build their own organelles inside infected cells. The characterization of these interactions will be fundamental to identify new targets for antiviral and antibiotic drug development. This review discusses how viruses and bacteria subvert cell machineries for lipid synthesis and transport and summarises the most promising compounds that interfere with these pathways. Emerging viruses and multidrug-resistant bacteria constitute a serious public health problem, which will likely become a global safety challenge over the next decades. Faced with this situation, the need for searching new broad-spectrum antivirals and antibiotics has emerged. Most antibiotics in late-stage clinical development belong to existing antibiotic classes, and a few are new compounds directed against novel targets (Fernandes & Martens, 2017) . Blocking cellular pathways used by pathogens in combined therapies against several targets is an interesting strategy to treat viral and bacterial infections while avoiding antiviral or antibiotic resistance. Classically, the study of pathogen-host interactions had been focused on proteins and nucleic acids from the pathogen and the host. However, in recent years, lipidomics has gained importance in virology and bacteriology. Lipids are much more than structural components of membranes or molecules for energy storage, and they also play important roles in cellular signalling and regulatory processes in both healthy and infected cells. The lipid composition of membranes affects their morphology and biophysical properties such as charge, curvature, width, packing defects, and fluidity. The study of changes in lipid biosynthesis pathways and transport in infected cells is a promising research field because many viruses and bacteria manipulate host membranes and lipid flows (Altan-Bonnet, 2017; Toledo & Benach, 2015; van der Schaar, Dorobantu, Albulescu, Strating, & van Kuppeveld, 2016) . In this review, we summarise the main pathways of lipid synthesis and transport hijacked by viruses and bacteria and the drugs that interfere with these general processes. Viruses are obligate intracellular pathogens that require the host cell machinery to replicate. Both DNA and RNA viruses usurp and take advantage of cellular membranes at different steps of their replication cycle. Viruses are able to induce the synthesis of new membranes and reorganise membranes of cell compartments to generate new organelles known as replication organelles or viral factories, which support viral genome replication and assembly of virus progeny. The use of membranes from organelles of the secretory pathway is quite widespread among RNA viruses. For instance, flaviviruses such as dengue virus (DENV), West Nile virus (WNV), and hepatitis C virus (HCV; Gillespie, Hoenen, Morgan, & Mackenzie, 2010; Romero-Brey et al., 2012; Welsch et al., 2009) , reoviruses (Tenorio et al., 2018) , and severe acute respiratory syndrome coronavirus (Knoops et al., 2008) *These two authors are equal contributors. exploit endoplasmic reticulum (ER) membranes. The Golgi apparatus is used by Bunyaviruses (Fontana, Lopez-Montero, Elliott, Fernandez, & Risco, 2008) and enteroviruses (Limpens et al., 2011) . Flock House virus (FHV) builds factories in mitochondria (Kopek, Perkins, Miller, Ellisman, & Ahlquist, 2007) , tomato bushy stunt virus (TBSV) uses peroxisomes (Fernandez de Castro, Fernandez, Barajas, Nagy, & Risco, 2017) , rubella virus uses lysosomes (Fontana et al., 2010) , and Sindbis virus assembles replication complexes at the plasma membrane, endosomes, and lysosomes (Frolova, Gorchakov, Pereboeva, Atasheva, & Frolov, 2010) . The development of metabolomics and lipidomics based on liquid chromatography and mass spectrometry techniques has contributed to characterize and monitor changes in the amount of different membrane and signalling lipids during viral infections. For instance, HCV infection has been discovered to increase cellular levels of cholesterol and sphingolipids (SLs) and to modify the phospholipid metabolism leading to an accumulation of phosphatidylcholine (PC) and triglyceride with longer and polyunsaturated fatty acid (FA) chains (Diamond et al., 2010; Gullberg et al., 2018; Hofmann et al., 2018; Roe, Kensicki, Mohney, & Hall, 2011) . Lipidomics analysis of cells infected with other related flaviviruses such as DENV and WNV has revealed a marked increase in FAs, glycerophospholipids (GPLs), and SL content (Chotiwan et al., 2018; Perera et al., 2012) and has allowed to identify specific markers of infection, for example, lysophosphatidylcholine (Liebscher et al., 2018) . These techniques have also allowed the characterization of the lipidome of enveloped viruses. By this way, human immunodeficiency virus-1 lipid envelope has been observed to be different from the producer cell plasma membrane, suggesting that viruses bud from specialised membrane subdomains, which are enriched in particular lipids (Lorizate et al., 2012) . Taken together, all these data prove the complex remodelling of the host lipid metabolism induced by viral infection. GPLs are the major components of biological membranes. Their structure is based on a polar group head, which defines their charge and shape properties and allows the interaction with water and molecules near the external leaflet of the membrane, and a pair of FA hydrophobic tails. The rate-limiting step of GPLs biosynthesis relies on FA availability. In order to generate a larger pool of FA, HCV directly induces the overexpression of FA synthase (FASN), the key multienzyme complex for FA synthesis and therefore GPLs. This is a possible mechanism by which HCV infection alters the cellular lipid profile in liver and causes diseases such as steatosis (Yang et al., 2008) . DENV nonstructural protein 3 (NS3) is responsible for FASN recruitment to replication factories (Heaton et al., 2010) . After infection, cellular membranes showed a FASN-dependent enrichment in unsaturated phospholipids and lipid signalling molecules such as sphingomyelin (SM; Perera et al., 2012) . Two related flaviviruses, WNV and Usutu virus (USUV; Martin-Acebes, Blazquez, Jimenez de Oya, Escribano-Romero, & Saiz, 2011) , and the nonrelated alphanodavirus FHV (Kampmueller & Miller, 2005) also showed an RNA replication dependency on FA synthesis. Thus, modulating FA synthesis can be an effective antiviral strategy. DENV, WNV, USUV, and FHV viruses are sensitive to the inhibitory effect of cerulenin and C75, two specific inhibitors of FASN. Cerulenin is a natural product of the fungus Cephalosporium caerulens, which only inactivates the β-ketoacyl synthase activity of FASN. C75 is a synthetic inhibitor that also inactivates the enoyl reductase and thioesterase partial activities of FASN with about the same rates as for inactivation of the β-ketoacyl synthase (Rendina & Cheng, 2005) . C75 was designed to be less reactive and safer than the classical inhibitor, cerulenin. Appropriate membrane packing and fluidity are essential for viral RNA replication. These membrane properties mostly depend on the saturation grade and length of the FA hydrophobic tales. The stearoyl-CoA desaturase 1 (SCD1) is a rate-limiting enzyme in the biosynthesis of monounsaturated FAs from their saturated FA precursors. It catalyses the formation of a cis-double bond at the Δ9 position of stearoyl and palmitoyl-CoA. Brome mosaic virus (BMV) requires unsaturated FAs, and mutations in the host FA desaturases inhibit BMV replication (Lee, Ishikawa, & Ahlquist, 2001) . Synthetic piperidine-aryl urea-based inhibitors such as A939572 have been developed to specifically block SCD1, and they have been proven to impair HCV and DENV infection in cell culture (Gullberg et al., 2018; Nguyen et al., 2014) . SCD1 inhibitors are claimed to be promising candidates to treat various diseases including cancer, Alzheimer's disease, and viral infections, so recently, novel SCD1 inhibitors have been developed and reported (reviewed by Uto, 2016) . PC and phosphatidylethanolamine (PE) are the most abundant GPLs in the cell. They are synthesized by two different metabolic routes, from a choline or ethanolamine polar head and a diacylglycerol backbone through the so-called Kennedy pathways, which are the most exploited ways by most mammalian cells, and through the CDP-DAG pathway that is the main PC source for yeast. This alternative pathway consists of a lineal route by which PE suffers three FIGURE 1 Schematic summary of host lipid synthesis and transport pathways used by viruses and bacteria. Compounds that interfere with these pathways and have antiviral or antibiotic activity are indicated. (1) Disruption of lipid rafts affects West Nile virus, Newcastle disease virus, human immunodeficiency virus-1, and influenza A, bovine parainfluenza, and syncytial viruses and Salmonella typhimurium, Shigella, Mycobacterium avium, Pseudomonas aeruginosa, and Chlamydia trachomatis infection. (2) Inhibition of phospholipase PLA2G4A impairs hepatitis C virus (HCV) replication. (3) Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase by statins interferes with infection of many viruses and bacteria such as West Nile virus (WNV), dengue virus (DENV), tomato bushy stunt virus, Chlamydia pneumoniae, Staphylococcus aureus, Staphylococcus pneumoniae, Mycobacterium tuberculosis, Klebsiella pneumoniae, Escherichia coli, and Coxiella burnetii. Global PC synthesis is significantly enhanced during infection of many (+)ssRNA viruses such as DENV, FHV, poliovirus, and HCV (Castorena, Stapleford, & Miller, 2010; Vance, Trip, & Paddon, 1980; Zhang et al., 2016) . Moreover, BMV replication protein 1a interacts with and recruits cho2 to the site of viral replication. In CHO2 deletion yeast mutants, BMV replication was inhibited up to 30-fold (Zhang et al., 2016) . On the other hand, the plant tombusviruses TBSV, cucumber necrosis virus, and Carnation Italian ringspot virus and the unrelated insect Nodamura virus require high levels of PE at the viral replication sites. All these viruses take advantage of the increased PE level in cho2Δ yeast cells, whereas depletion of the PE levels reduces viral replication (Xu & Nagy, 2015) . As PE has a small head resulting in a conical shape, it has been proposed to contribute to the induction of the characteristic negative curvature of single-membrane vesicles or spherules with VRCs (Altan-Bonnet, 2017). In addition, at the replication complex, the TBSV RNA-dependent RNA polymerase (RdRp) is stimulated upon PE binding (Xu & Nagy, 2015) but inhibited by phosphatidylglycerol. Although further investigation is needed to identify the particular PC and PE synthesis pathways used by different viruses, the fact that PS accumulation has been usually associated to PS receptordependent uptake or "apoptotic mimicry," as we discuss below. FIGURE 2 Schematic summary of phosphatidylinositol (PI)-derived signalling pathways triggered by bacteria and viruses. Compounds that interfere with these pathways and have antiviral or antibiotic activity are indicated. (1) Listeria uses the InIB effector, which engages with host receptor Met and stimulates the recruitment of PI3KI to the bacterial entry sites. PI3K activation produces PI(3,4,5)P3, resulting in the reorganisation of cytoskeleton favouring the entry of Listeria. Both Listeria and Chlamydia additionally recruit PI4KIIα/β to the plasma membrane, where it produces PI(4)P also promoting uptake. (2) Brucella and Salmonella require PI3KI recruitment and activity for entering the cell. Alternately, Anaplasma phagocytophilum and Shigella need the subsequent PI3K-AKT pathway to delay apoptosis. Moreover, Shigella's entry site requires an enrichment of PI(5)P stimulated by IpgD. (3) After entry, Chlamydia recruits PI4KIIα to the inclusion, generating PI(4)P and leading to the recruitment of the lipid transfer protein oxysterol-binding protein (OSBP). (4) Mycobacterium produces the mannose-capped lipoarabinomannan (ManLAM) to interfere with PI3KIII activity. Disruption of PI3KIII reduces the amounts of PI(3)P on the inclusion surface and avoids phagosomal maturation. (5) Recruitment of PI4KIIIβ and OCRL1 together with the hijacking of the secretory pathway enriches Legionella inclusion in PI(4)P. (6) The Salmonella effector SopB recruits PI3KIII to the inclusion surface to maintain high levels of PI(3)P. The SseL effector binds to OSBP, which is recruited to the inclusion periphery. (7) Many different viruses recruit and exploit host PI4KIII kinases to build viral factories within reorganised cell membranes. Hepatitis C virus and encephalomyocarditis virus remodel endoplasmic reticulum membranes to build replication organelles with the assistance of PI4KIIIα that generates PI(4)P at the replication sites. In a similar manner, PI4KIIIβ is used by other viruses such as picornaviruses, enteroviruses, Coxsackievirus B3, and human rhinoviruses 2.1.2 | Regulation of lipid rafts and cholesterol synthesis The cholesterol and SL content in biological membranes defines important physical and biological properties. These lipids do not homogeneously distribute in membranes but together constitute detergent-resistant domains or lipid rafts, which are involved in membrane trafficking and cell signalling. Cholesterol is a critical membrane component that determines membrane fluidity, helps to stabilise the curvature and packing defects of membranes, and regulates the formation and function of membrane-bound complexes of lipids and proteins. Viruses take advantage of these properties to make specialised membrane platforms for RNA replication and virus assembly. Lipid rafts have been proven to participate in key steps of the life of viruses, such as entry, RNA translation, virus progeny assembly, and egress (Shahsavandi, Ebrahimi, & Hasaninejad Farahani, 2017) . In fact, many viruses are sensitive to inhibitors of HMGCR, the rate-limiting enzyme of cholesterol biosynthesis. This is the case of statins used for treating hypercholesterolaemia in humans. Statins act by competitively inhibiting HMGCR. Because their molecular structure is similar to HMG-CoA, statins fit into the catalytic active site of the enzyme and compete with the native substrate. This competition reduces the rate by which HMGCR produces mevalonate, the next molecule in the cascade that eventually generates cholesterol (Stancu & Sima, 2001) . Thus, statins deplete cholesterol and disrupt lipid rafts. For example, WNV, DENV, and TBSV are inhibited by lovastatin (Mackenzie et al., 2007; Rothwell et al., 2009; Sharma, Sasvari, & Nagy, 2010 ; Soto-Acosta, Bautista-Carbajal, Cervantes-Salazar, Angel-Ambrocio, & Del Angel, 2017), and DENV and human immunodeficiency virus-1 are inhibited by simvastatin (Bryan-Marrugo et al., 2016; DeLucia, Rinaldo, & Rappocciolo, 2018) . HCV is also sensitive to different statins (Amemiya et al., 2008; Kim et al., 2007; Rao & Pandya, 2011) . Lipidomics studies have shown an increase in the content of ceramide (Cer) and SM in flavivirus-infected cells. Cer has specifically been associated with WNV replication and viral particle biogenesis. SM is enriched in VRC membranes of viruses phylogenetically related to WNV, such as DENV and HCV (Martin-Acebes et al., 2016) . infection. Other host factor involved in the recruitment of HCV to LD is the lipid-modifying phospholipase PLA2G4A (Menzel, 2012) . Picornaviruses have also been shown to utilise a different A2 phospholipase, the PLA2G16. In this case, the enzyme assists in genome delivery from virions into the cytoplasm after entry in cells (Staring et al., 2017) . PI-related lipids have recently emerged as signalling molecules involved in nearly all aspects of cellular regulation. The production of PI4P has been described to play a key regulatory role for a wide range of cellular activities, including membrane trafficking and biogenesis, via the recruitment of effector proteins related to lipid biosynthesis and transport. The major pool of PI4P is synthesized in Golgi membranes by PI 4-kinases type 3 (PI4KIII), distinguishing two different isoforms In contrast, PIK93 inhibits both PI4KIIIβ and PI4PIIIα isoforms. This compound is efficient against enteroviruses, including poliovirus and Coxsackievirus B3, human rhinoviruses (Arita, 2014; Arita et al., 2011; Roulin et al., 2014) , and HCV (Hsu et al., 2010) . The PIK93 lack of specificity for PI4KIII isoforms and the fact that it inhibits PI3Ks at high concentrations raise concern about its use as an antiviral agent (Bishe, Syed, & Siddiqui, 2012) . Although in vitro studies have not found significant problems with cellular viability, some in vivo studies have shown that animals treated with PIK93 and other related small PI4Ks inhibitors suffered from adverse effects. However, given that In most instances, proteins are delivered to their final destination in particular membranes by vesicular shuttles that originate at the ER and follow the secretory pathway. However, for many lipids, there are nonvesicular modes of transport. These are faster than vesicular trafficking and produce local lipid enrichment and considerable asymmetries in the lipid composition of membranes. Nonvesicular transport also ensures the supply of lipids to organelles out of the secretory pathway, such as mitochondria. Because lipids are insoluble in water, during nonvesicular transport, they are shielded from the water-rich cytoplasm by proteins that hold them in an internal hydrophobic pocket. Such lipid transfer proteins (LTPs) often act in regions in which one organelle comes~30 nm away from another membrane, the so-called MCSs (Wong, Copic, & Levine, 2017) . Plants induce LTPs' expression and secretion as a defence mechanism against pathogens (Kushwaha, Singh, Basu, & Chakraborty, 2015; Ooi et al., 2008; Park et al., 2002; Sohal, Pallas, & Jenkins, 1999) . On the other hand, animal viruses hijack LTPs that mobilise cholesterol and SLs to build their replication neo-organelles. The best documented cases are described in the next sections. Both Cer transfer protein (CERT) and four-phosphate adaptor protein 2 (FAPP2) mediate the traffic of SL precursors. Because these LTPs accumulate SLs at the replication sites, they are good targets to interfere with flaviviruses. CERT is responsible for transferring Cer from ER to Golgi where synthesis of complex SLs takes place (Hanada et al., 2003) . CERT is necessary for HCV egress (Bishe et al., 2012) , and its pharmacological inhibition with the synthetic compound HPA-12 dramatically impairs HCV release (Aizaki et al., 2008; Yasuda et al., 2001) . Moreover, CERT and OSBP are regulated by protein kinase D, so that phosphorylated forms of both LTPs are inactive (Amako, Syed, & Siddiqui, 2011) . Drugs interfering with host protein kinase D such as CRT0066101, a PKD-specific small-molecule inhibitor (Harikumar et al., 2010) , might become efficient antivirals. The FAPP2 docks the Golgi through PI4P and shuttles glucosylceramide (Godi et al., 2004) , a substrate of a subset of complex glycosphingolipids. FAPP2 localizes to HCV replication sites and mediates the accumulation of lactosylceramide at the VRCs. FAPP2 depletion disrupts HCV replication complexes and impairs HCV replication (Khan et al., 2014) . Niemann-Pick type C1 protein (NPC1) was discovered while studying a human neurodegenerative disease characterized by the disruption of subcellular cholesterol transport. NPC1 is a glycoprotein with 13 transmembrane domains that localizes to late endosomes and transiently in lysosomes and trans-Golgi network. NPC1 acts in tandem with NPC2 to carry out the transfer of extracellular and recycled free cholesterol from the endosomal/lysosomal system to trans-Golgi network and ER (Ioannou, 2000) . NPC1 is the cell receptor of Ebola virus, Marburg virus, and other filoviruses (Carette et al., 2011) . U18666A has been developed as a specific inhibitor of NPC1 (Lu et al., 2015) . The administration of U18666A and other multiple cationic amphiphiles induces the accumulation of cholesterol in endosomes and lysosomes and inhibits Ebola entry and infection (Shoemaker et al., 2013) . Targeting NPC1 also impairs the replication of other RNA viruses such as DENV (Poh et al., 2012) and hepatitis E virus (Yin, Ambardekar, Lu, & Feng, 2016 ). NPC1 has not been found to be the cellular receptor for these viruses, so the adverse effects on viral replication after treatment with U18666A or NPC1 depletion must be due to effects at a postentry step. In the case of HCV, which takes advantage of the cellular endosomal and exosomal pathways to egress from the host cell, U18666A blocks the release of viral particles by inhibiting NPC1 and therefore the transport and functionality of multivesicular bodies. This leads to an accumulation of mature viral particles in exosomes. Moreover, U18666A leads to the formation of large dysfunctional lysosome-like structures that mediate the degradation of these viral particles (Elgner et al., 2016) . Bacteria have developed a number of strategies to modify host lipids during infection. The nature and effects of these changes are not fully understood, but it is known that some bacteria manipulate lipids to survive inside eukaryotic cells or to spread by triggering cell death (Toledo & Benach, 2015) . Signalling cascades related to cholesterol, SLs, and phosphoinositides are particularly relevant during bacterial infections. Many different bacteria need cholesterol for entering cells or building neo-organelles (Stehr, Elamin, & Singh, 2012) . However, bacteria cannot synthetize cholesterol and need to obtain it from the infected cell. Acid sphingomyelinase (Asm) is one of the hydrolases that generates Cer from SM. Asm activation produces Cer-enriched domains in the plasma membrane that are used by bacteria for entering cells or to trigger apoptosis. On the other hand, Asm is also crucially involved in the host response against pathogenic bacteria. Finally, phosphoinositides (PtdIns) and related enzymes control many processes including vesicular trafficking, actin polymerisation, and different signalling cascades that can modify membranes during phagocytosis or activate the endocytic pathway. Bacteria hijack all these pathways together with LTPs. Here, we summarise the strategies used by different pathogenic bacteria to subvert lipid synthesis and transport. Targeting these pathways can generate new efficient antibiotics (summarised in Figures 1 and 2 ). De novo cholesterol biosynthesis occurs in the ER, with the conversion of HMG-CoA to mevalonate by HMGCR. Cellular cholesterol levels can also be increased by the uptake of cholesterol bound to low-density lipoprotein (LDL) via the LDL receptor. When cellular cholesterol levels are high, it can be transported out of the cell, broken down into bile acids or steroids, or esterified and stored in LDs. In eukaryotic cells, cholesterol and SLs are the main components of membrane microdomains known as lipid rafts. These microdomains that contain tightly packed receptor clusters and other signalling proteins are involved in many signal transduction pathways. Anaplasma phagocytophilum and Brucella species enter cells in a lipid raft-dependent manner (Naroeni & Porte, 2002; Xiong, Lin, & Rikihisa, 2009) . Pharmacological disruption of cholesterol flows impairs the assembly of lipid rafts. Thus, treatment with U18666A (Xiong & Rikihisa, 2012) , ketoconazole, or filipin III Watarai, Makino, Fujii, Okamoto, & Shirahata, 2002) makes these bacteria incapable of infecting cells. Chlamydia has developed different strategies to incorporate lipids via vesicular and nonvesicular transport (Hackstadt, Scidmore, & Rockey, 1995; Hatch & McClarty, 1998; Wylie, Hatch, & McClarty, 1997) . Cholesterol depletion with MβCD (Jutras, Abrami, & Dautry-Varsat, 2003; Korhonen et al., 2012) , simvastatin (Erkkila et al., 2005) , U18666A (Beatty, 2006) , and an acyl-CoA:cholesterol acyltransferase inhibitor (Peters & Byrne, 2015) have shown that elementary bodies, the extracellular infectious stage of Chlamydia, attaches to cholesterol-rich sites at the plasma membrane. However, the importance of lipid rafts in Chlamydia entry is a matter of controversy because some studies have shown that Chlamydia can enter cells in a way that does not depend on lipid rafts (Gabel, Elwell, van Ijzendoorn, & Engel, 2004; Norkin, Wolfrom, & Stuart, 2001) . Contradictory results can be attributed to studies with various bacterial isolates and different host cells. After entering cells, A. phagocytophilum, Brucella, Mycobacterium, Salmonella, Chlamydia, and Coxiella burnetii establish their replicative inclusions in membrane-bound compartments derived from phagosomes or organelles of the endocytic pathway (Alpuche-Aranda, Berthiaume, Mock, Swanson, & Miller, 1995; Heinzen, Scidmore, Rockey, & Hackstadt, 1996; Niu, Yamaguchi, & Rikihisa, 2008; Oh et al., 1996) . Although these bacteria lack the genes for cholesterol biosynthesis, cholesterol content increases in infected cells. In particular, Chlamydia spp., C. burnetii, and A. phagocytophilum modulate host cholesterol homeostasis at the level of gene transcription, such as the LDL receptor or the HMGCR (Gilk, 2012; Lin & Rikihisa, 2003) . Chlamydia downregulates cholesterol efflux and requires de novo cholesterol synthesis (Bashmakov, Zigangirova, Pashko, Kapotina, & Petyaev, 2010) , whereas A. phagocytophilum alters LDL uptake by infected cells and causes a twofold increase of their cholesterol content (Xiong et al., 2009) . C. burnetii increases the cholesterol content of infected cells by 70% (Czyz et al., 2014; Howe & Heinzen, 2006) . During early stages of infection, the inclusion membrane of C. burnetii has low levels of cholesterol, but at later stages, the amount of cholesterol increases, which suggests a temporal regulation of cholesterol biosynthesis and uptake. C. burnetii has been shown to be sensitive to the treatment with statins (Howe & Heinzen, 2006) . Mycobacterium and Salmonella do not need lipid rafts for entry, but intracellular cholesterol is important for infection. As mentioned above, Mycobacterium cannot synthesize cholesterol and needs to obtain cholesterol from the host through alternative means such as the mce4 gene cluster and the ABC-like-ATP-dependent system that import cholesterol into bacteria. Disrupting cholesterol metabolism diminishes Mycobacterium entry (Kaul, Anand, & Verma, 2004 ), replication (de Chastellier & Thilo, 2006 Miner, Chang, Pandey, Sassetti, & Sherman, 2009; Mohn et al., 2008; Parihar et al., 2014; Russell, Cardona, Kim, Allain, & Altare, 2009) , and subsequent stages of infection (Nesbitt et al., 2010; Pandey & Sassetti, 2008) . Salmonella uses the pathogenicity island 1 and 2 type III secretion systems that localize in the lumen of the inclusion, where they mediate the esterification of cholesterol (Haraga, Ohlson, & Miller, 2008; Nawabi, Catron, & Haldar, 2008) . Pharmacological disruption of cholesterol with statins (Catron et al., 2004) or MβCD (Huang, 2011) reduces intracellular Salmonella growth. Other bacteria such as Pseudomonas aeruginosa (Kowalski & Pier, 2004) , Staphylococcus pneumoniae (Bergman et al., 2011) , Staphylococcus aureus (Jerwood & Cohen, 2008) Although incorporation of Cer to lipid rafts is essential for the initiation of cell defence against pathogens such as Salmonella (Huang, 2016; McCollister, Myers, Jones-Carson, Voelker, & Vazquez-Torres, 2007) , this process is used by some bacteria to infect cells. During Mycobacterium-containing vacuole with the phagosome, a process that mediates the elimination of bacteria (Vazquez et al., 2016) . Mycobacterium avoids this host defence via PI signalling. Thus, Mycobacterium tuberculosis synthesizes glycosylated phosphoinositides such as mannose-capped lipoarabinomannan (ManLAM; Beatty et al., 2000; Fratti, Chua, Vergne, & Deretic, 2003) . Furthermore, the phosphatase activity of SapM, MptpB, and MptpA reduces the amount of PtdIns (3) P on the Mycobacterium-containing vacuole surface (Chua & Deretic, 2004) . Both ManLAM and phosphatase effectors interfere with phagosomal maturation and degradation of bacteria (Castandet et al., 2005; Singh et al., 2003) . Interestingly, Asm is also important for Mycobacterium infection. Pharmacological inhibition of Asm with imipramine (Godbole et al., 2015) and infection in Asm-deficient mice (Utermohlen, Herz, Schramm, & Kronke, 2008) showed that the growth of M. tuberculosis, Mycobacterium smegmatis, and Mycobacterium avium was blocked. Moreover, Asm-deficient mice were more resistant to Mycobacterium lethal infection than wild-type mice. Additionally, both Neisseria and Pseudomonas trigger Asm activation, Cer release, and the assembly of Cer-enriched rafts that are essential for infection (Grassme et al., 1997; Grassme et al., 2003; Hauck et al., 2000) . Cer-enriched platforms serve as scaffold for the recruitment of cellular receptors such as the cystic fibrosis transmembrane conductance regulator, used by Pseudomonas to enter cells (Schroeder et al., 2002) . Deficiency of Asm and specific pharmacological inhibition blocked Neisseria (Grassme et al., 1997; Hauck et al., 2000; Simonis, Hebling, Gulbins, Schneider-Schaulies, & Schubert-Unkmeir, 2014) and and E. coli (Falcone et al., 2004) , demonstrating their potential as broad-spectrum antibiotics. Chlamydia incorporates lipid storage organelles into the inclusion lumen (Cocchiaro, Kumar, Fischer, Hackstadt, & Valdivia, 2008) , and it has its own machinery to synthetize GPLs such as PE, phosphatidylglycerol, and PS but needs to hijack other host-derived lipids such as FAs. Chlamydia also needs to transport cholesterol and SLs to the bacterial cell wall (Yao, Cherian, Frank, & Rock, 2015; Yao, Dodson, Frank, & Rock, 2015) . There is a close association between Golgi apparatus, where SM is synthetized, and Chlamydia inclusions. Chlamydia intercepts the exocytic transport of SMcontaining vesicles and redirects them to the inclusions (Wolf & Hackstadt, 2001) . For this purpose, Chlamydia also uses the CERT whose role in infection will be discussed below. Two mayor signalling cascades have been proposed for Listeria invasion (Mengaud et al., 1996; Shen, Naujokas, Park, & Ireton, 2000) . These two pathways depend on virulence factors InIA or InIB. InIB interaction with its natural receptor Met (Marino, Braun, Cossart, & Ghosh, 1999; Shen et al., 2000) triggers the activation and translocation of PI3KIA to Listeria monocytogenes entry site. The subsequent signalling cascade produces an increase in lipid products, in particular PI(3,4,5)P3 (Ireton et al., 1996; Ireton, Payrastre, & Cossart, 1999 ) that recruits effectors for actin reorganisation. PI3K cascade and cytoskeletal rearrangements are critical for L. monocytogenes invasion, and that is why PI3K inhibitors such as wortmannin and LY294002 block infection (Ireton et al., 1996) . During Shigella infection, the sites of internalisation colocalize with PI(5) P, which is produced with the participation of the bacterial phosphatase IpgD. The accumulation of PI5P at the plasma membrane reduces tether forces and favours entry. When PI3KI-AKT pathway is activated, the regulation of antiapoptotic effectors is triggered. However, blocking PI3K with wortmannin does not affect Shigella entry, suggesting that PI3KI activity is not involved in invasion but in later steps of infection (Lafont, Tran Van Nhieu, Hanada, Sansonetti, & van der Goot, 2002; Pendaries et al., 2006) . A. phagocytophilum also takes advantage of the PI3K-AKT pathway to delay apoptosis, something observed in experiments of PI3K pharmacological inhibition with LY294002 (Khanal, Sultana, Catravas, Carlyon, & Neelakanta, 2017; Sarkar et al., 2012) . Brucella also requires both PI3KI and PI3KII activity for entering the cell and replicate (Guzman-Verri et al., 2001) . Salmonella can modulate PIderived signalling at different stages of infection via the bacterial phosphatase effector SopB. By a not well-understood SopBdependent process, PI3KI converts PI(4,5)P2 to PI(3,4,5)P3 at the plasma membrane and produces a double effect: First, the reduction of interactions between membrane and cytoskeleton leads to bacterial invasion (Terebiznik et al., 2002) , and second, the recruitment of AKT activates cell survival pathways that avoid apoptosis. SopB also reduces PI(4,5)P2 and PS levels on the Salmonella vacuole surface, where charge diminishes avoiding the fusion with lysosomes (Bakowski et al., 2010) . Another essential SopB function for Salmonella replication is the recruitment of Rab5 and PI3KIII to the inclusion surface, which is required to maintain high levels of PI(3)P (Bujny et al., 2008; Hernandez, Hueffer, Wenk, & Galan, 2004) . Two studies (Auweter et al., 2011; Auweter, Yu, Arena, Guttman, & Finlay, 2012) showed that SseL, another Salmonella effector, interacts with the lipid transfer protein OSBP and enhances Salmonella replication, probably by modifying the lipid composition of the replicative vacuole. In contrast, Mycobacterium alters PI(3)P levels by a dual strategy. Mycobacterium encodes different phosphatase effectors to arrest phagosomal maturation and avoid its elimination by reducing the amount of PI(3)P on the Mycobacterium inclusion surface (Castandet et al., 2005; Singh et al., 2003) . Mycobacterium also expresses a glycosylated PI analogue, the ManLAM, that inhibits the activation of PI3KIII, the kinase involved in PI(3)P production. Chlamydia activates phosphoinositide-dependent signalling pathways such as PDPK1-MYC (Al-Zeer et al., 2017) and PI3K-AKT (Zou et al., 2018) to favour infection and survival. PI4KII has been shown to be important for Chlamydia and Listeria infection. In addition to PI3K, the activation of PI4KII is required for Listeria invasion, and its blockade impairs entry without perturbing the plasma membrane content in PI (4,5)P2 and PI(3,4,5)P3 (Pizarro-Cerda et al., 2007) . Although the participation of PI4K in Listeria infection is not well understood, these results suggest a postentry signalling role. Legionella modifies PI flows with a number of effectors that interfere with endocytic and secretory pathways and with communication with the ER. Legionella pneumophila hijacks PC and diacylglycerol on the Legionella-containing vacuole membrane (Viner, Chetrit, Ehrlich, & Segal, 2012) . Furthermore, it is known that L. pneumophila enriches its inclusion membrane with PI(4)P in a PI4KIII-dependent manner (Brombacher et al., 2009; Weber, Ragaz, Reus, Nyfeler, & Hilbi, 2006) . Additionally, treatment with the PI4KIII inhibitor PIK93 reduces L. pneumophila replication (Hubber et al., 2014) , confirming the importance of the PI4Ks in Legionella infection. However, the requirement of PI3K in L. pneumophila entry and replication has been a matter of debate (Charpentier et al., 2009; Khelef, Shuman, & Maxfield, 2001; Tachado, Samrakandi, & Cirillo, 2008; Weber et al., 2006) . Chlamydia recruits PI4KIIα, has high levels of PI4P in the membrane inclusion, and recruits the lipid transfer protein OSBP in a PI4P-dependent way. Although its role is still unclear, OSBP probably participates in inclusion membrane remodelling by modifying its lipid composition (Moorhead, Jung, Smirnov, Kaufer, & Scidmore, 2010) , something that could make Chlamydia sensitive to inhibitors of OSBP. Although little is known about how bacteria interfere with lipid trafficking, it has been reported that some bacteria hijack LTPs. The best documented cases are described below. Pharmacological inhibition and genetic deficiency studies showed that NPC1 is used by A. phagocytophilum and Brucella. Recruitment of NPC1 produces an accumulation of cholesterol in the inclusions of A. phagocytophilum. Moreover, treatment with the NPC1 inhibitor U18666A blocks the transport of cholesterol to the bacterial inclusion and stops bacterial growth, evidencing the essential role of this LTP in infection (Xiong et al., 2009; Xiong & Rikihisa, 2012) . In the case of Brucella, lipid rafts are important for the entry of bacteria in the host cell (Watarai, Makino, Michikawa, et al., 2002) . Because NPC1 is important for the maintenance of cholesterol-rich lipid rafts, targeting NPC1 blocks Brucella infection. Therefore, NPC1-deficient mice are resistant to Brucella infection (Watarai, Makino, Fujii, et al., 2002) . U18666A is efficient also against C. burnetii and Chlamydia trachomatis (Beatty, 2006; Howe & Heinzen, 2006) , but the role of NPC1 in infection is still unknown. As mentioned before, CERT transports Cer from the ER membrane to the Golgi apparatus where the SM synthase 1 transforms it into SM. Chlamydia cannot synthesize SLs that are essential for the biogenesis of bacterial inclusions and replication of bacteria (van Ooij et al., 2000) . Cryo-electron microscopy and immunogold labelling showed that CERT is recruited to bacterial inclusions. Chlamydia uses CERT to transport Cer from the ER to the bacterial inclusion for SM synthesis (Derre, Swiss, & Agaisse, 2011; Elwell et al., 2011) . SM then incorporates into the inclusion membrane and the bacterial cell wall. The compound HPA-12 has been reported as a specific CERT inhibitor. However, in CERT-knockout cells, SL transport still works, and HPA-12 strongly impairs this transport (Carabeo, Mead, & Hackstadt, 2003; Elwell et al., 2011; Koch-Edelmann et al., 2017) . These results suggest that HPA-12 is an inhibitor of Cer transporters other than CERT. Oxysterol-binding protein-related protein 1 (ORP1L) belongs to the OSBP-related protein family. ORP1L acts as a cholesterol sensor that modulates the formation of MCSs between the late endosomes and the ER. It has been recently reported that Coxiella recruits ORP1L to MCSs formed between the bacterial inclusion and the ER, which is followed by changes in the membrane properties of the inclusion vacuole (Justis et al., 2017; Wallqvist et al., 2017) . ORP1L attaches to the Coxiella-containing vacuole membrane through its N-terminal ankyrin repeats that are involved in protein-protein interactions, but the specific function of ORP1L in the infection is still unclear. Therapeutic approaches based on specific factors of host-pathogen interactions are a promising avenue to overcome treatment failure in infectious diseases. Lipids are gaining importance as targets for antiviral and antibiotic development. Because many viruses and bacteria use lipids to build neo-organelles for replication and persistence, inhibitors of the synthesis of cholesterol, Cer, SLs, FAs, and phospholipids interfere with growth of many pathogens. Besides, drugs against protein kinases target signalling pathways needed for infection. Figures 1 and 2 summarise current knowledge on host lipid synthesis, transport, and signalling pathways used by viruses and bacteria. Compounds that interfere with these pathways may become efficient antivirals or antibiotics. Moreover, drugs tested against viruses might be efficient also against bacteria and vice versa. Notably, targeting lipid transport may produce less toxic antivirals and antibiotics as intracellular pathogens depend on specific LTPs for making their neo-organelles, although cells may have more than one LTP for the same function. Within this context, high-throughput screening of clinically tested compounds will provide a rapid means to identify undiscovered, antiviral, and antibiotic functions for well-characterized molecules that target lipid metabolism and flows. The authors declare to have no conflicts of interest. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners Oxysterol-binding protein (OSBP) enhances replication of intracellular Salmonella and binds the Salmonella SPI-2 effector SseL via its Nterminus Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis Trafficking and release of mycobacterial lipids from infected macrophages Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis Studies on the antibacterial effects of statins-In vitro and in vivo Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death and Differentiation Phosphoinositides in the hepatitis C virus life cycle Rab1 guanine nucleotide exchange factor SidM is a major phosphatidylinositol 4-phosphate-binding effector protein of Legionella pneumophila The antidengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression Sorting nexin-1 defines an early phase of Salmonellacontaining vacuole-remodeling during Salmonella infection Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 Tyrosine phosphatase MptpA of Mycobacterium tuberculosis inhibits phagocytosis and increases actin polymerization in macrophages Complementary transcriptomic, lipidomic, and targeted functional genetic analyses in cultured Drosophila cells highlight the role of glycerophospholipid metabolism in Flock House virus RNA replication Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation Chemical genetics reveals bacterial and host cell functions critical for type IV effector translocation by Legionella pneumophila Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry Dynamic remodeling of Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virions The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development Effect of simvastatin, an established lipidlowering drug, on pulmonary Chlamydia pneumoniae infection in mice Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: Key events in Escherichia coli-elicited apoptosis of dendritic cells Antibiotics in late clinical development Three-dimensional imaging of the intracellular assembly of a functional viral RNA replicase complex Three-dimensional structure of rubella virus factories The unique architecture of Bunyamwera virus factories around the Golgi complex Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest Functional Sindbis virus replicative complexes are formed at the plasma membrane Lipid raft-mediated entry is not required for Chlamydia trachomatis infection of cultured epithelial cells Role of lipids in Coxiella burnetii infection The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion Stearoly-CoA desaturase 1 differentiates early and advanced dengue virus infections and determines virus particle infectivity GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: Direct activation of Cdc42 Lipid metabolism in Chlamydia trachomatis-infected cells: Directed trafficking of Golgiderived sphingolipids to the chlamydial inclusion Molecular machinery for non-vesicular trafficking of ceramide Salmonellae interplay with host cells A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis Metabolism and regulation of glycerolipids in the yeast Saccharomyces cerevisiae Efficient hepatitis C virus particle formation requieres diacylglycerol acyltransferase-1 Salmonella modulates vesicular traffic by altering phosphoinositide metabolism Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication Fat(al) attraction: Picornaviruses usurp lipid transfer at membrane contact sites to create replication organelles A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ Coxiella burnetii inhabits a cholesterolrich vacuole and influences cellular cholesterol metabolism Viral reorganization of the secretory pathway generates distinct organelles for RNA replication Plasma membrane cholesterol plays a critical role in the Salmonella-induced anti-inflammatory response in intestinal epithelial cells De novo sphingolipid synthesis is essential for Salmonella-induced autophagy and human beta-defensin 2 expression in intestinal epithelial cells The machinery at endoplasmic reticulum-plasma membrane contact sites contributes to spatial regulation of multiple Legionella effector proteins Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication The structure and function of the Niemann-Pick C1 protein A role for phosphoinositide 3-kinase in bacterial invasion The Listeria monocytogenes protein InlB is an agonist of mammalian phosphoinositide 3-kinase Unexpected antimicrobial effect of statins Interactions between the Coxiella burnetii parasitophorous vacuole and the endoplasmic reticulum involve the host protein ORP1L Entry of the lymphogranuloma venereum strain of Chlamydia trachomatis into host cells involves cholesterol-rich membrane domains The cellular chaperone heat shock protein 90 facilitates Flock House virus RNA replication in Drosophila cells Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I Cholesterol-sensor initiates M. tuberculosis entry into human macrophages Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2 Anaplasma phagocytophilum infection modulates expression of megakaryocyte cell cycle genes through phosphatidylinositol-3-kinase signaling Phagocytosis of wildtype Legionella pneumophila occurs through a wortmannin-insensitive pathway A cell-based, high-throughtput screen for small molecule regulators of hepatits C virus SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum The cellular ceramide transport protein CERT promotes Chlamydia psittaci infection and controls bacterial sphingolipid uptake Three-dimensional analysis of a viral RNA replication complex reveals a virus-induced mini-organelle Chlamydia pneumoniae entry into epithelial cells by clathrin-independent endocytosis Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation Differential response of diverse solanaceous hosts to tomato leaf curl New Delhi virus infection indicates coordinated action of NBS-LRR and RNAimediated host defense Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction Mutation of host Δ9 fatty acid desaturase inhibits brome mosaic virus RNA replication between template recognition and RNA synthesis Cholesterol-rich lipid rafts play a critical role in bovine parainfluenza virus type 3 (BPIV3) infection. Research in Veterinary Science Phospholipase A2 activity during the replication cycle of the flavivirus West Nile virus Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus The transformation of enterovirus replication structures: A three-dimensional study of single-and double-membrane compartments Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection Cholesterol manipulation by West Nile virus perturbs the cellular immune response Structure of the lnlB leucine-rich repeats, a domain that triggers host cell invasion by the bacterial pathogen L. monocytogenes Cholesterol dependence of Newcastle disease virus entry West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids Host sphingomyelin increases West Nile virus infection in vivo Constitutive acid sphingomyelinase enhances early and late macrophage killing of Salmonella enterica serovar Typhimurium Antibodies to the leucine-rich repeat region of internalin block entry of Listeria monocytogenes into cells expressing E-cadherin. Infection and Immunity MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles Role of cholesterol in Mycobacterium tuberculosis infection The actinobacterial mce4 locus encodes a steroid transporter Multiple host proteins that function in phosphatidylinositol-4-phosphate metabolism are recruited to the chlamydial inclusion. Infection and Immunity Role of cholesterol and the ganglioside GM(1) in entry and short-term survival of Brucella suis in murine macrophages Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol Stearoyl coenzyme A desaturase I is associated with hepatitis C virus replication complex and regulates viral replication Subversion of cellular autophagy by Anaplasma phagocytophilum Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium Isolation, characterization, molecular cloning and modeling of a new lipid transfer protein with antiviral and antiproliferative activities from Narcissus tazetta Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis Mycobacterial persistence requires the utilization of host cholesterol Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation Induction of pepper cDNA encoding a lipid transfer protein during the resistance response to tobacco mosaic virus PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis Dengue virus infection perturbs lipid homeostasis in infected mosquito cells Chlamydia trachomatis growth depends on eukaryotic cholesterol esterification and is affected by acyl-CoA: cholesterol acyltransferase inhibition Type II phosphatidylinositol 4-kinases promote Listeria monocytogenes entry into target cells U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment Characterization of the inactivation of rat fatty acid synthase by C75: Inhibition of partial reactions and protection by substrates Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis Metabolomic profile of hepatitis C virus-infected hepatocytes Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication Cholesterol biosynthesis modulation regulates dengue viral replication Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface Foamy macrophages and the progression of the human tuberculosis granuloma Design and structural characterization of potent and selective inhibitors of phosphatidylinositol 4 kinase IIIβ Host sphingolipid biosynthesis as a target for hepatitis C virus therapy Infection with Anaplasma phagocytophilum activates the phosphatidylinositol 3-kinase/Akt and NF-κB survival pathways in neutrophil granulocytes CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-κB translocation. Proceedings of the National Academy of Sciences of the United States of America Interfering with lipid raft association: A mechanism to control influenza virus infection by Sambucus nigra Inhibition of sterol biosynthesis reduces tombusvirus replication in yeast and plants InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases The promoter of a Brassica napus lipid transfer protein gene is active in a range of tissues and stimulated by light and viral infection in transgenic Arabidopsis DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target Statins: Mechanism of action and effects PLA2G16 represents a switch between entry and clearance of Picornaviridae Cytosolic lipid inclusions formed during infection by viral and bacterial pathogens Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein Non-opsonic phagocytosis of Legionella pneumophila by macrophages is mediated by phosphatidylinositol 3-kinase Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication Reovirus σNS and μNS proteins remodel the endoplasmic reticulum to build replication neoorganelles Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella Hijacking and use of host lipids by intracellular pathogens Fusogenicity of membranes: The impact of acid sphingomyelinase on innate immune responses Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors Poliovirus increases phosphatidylcholine biosynthesis in HeLa cells by stimulation of the ratelimiting reaction catalyzed by CTP: Phosphocholine cytidylyltransferase The proneurotrophin receptor sortilin is required for Mycobacterium tuberculosis control by macrophages Identification of two Legionella pneumophila effectors that manipulate host phospholipids biosynthesis Mechanisms of action of Coxiella burnetii effectors inferred from host-pathogen protein interactions Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication Macrophage plasma membrane cholesterol contributes to Brucella abortus infection of mice Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole Composition and three-dimensional architecture of the dengue virus replication and assembly sites Expanding roles for lipid droplets Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells Advances on the transfer of lipids by lipid transfer proteins Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis Cholesterol-dependent Anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production Chlamydia trachomatis relies on autonomous phospholipid synthesis for membrane biogenesis Chlamydia trachomatis scavenges host fatty acids for phospholipid synthesis via an acyl-acyl carrier protein synthetase A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses Positive-strand RNA viruses stimulate host phosphatidylcholine synthesis at viral replication sites Chlamydia trachomatis plasmid-encoded protein Pgp3 inhibits apoptosis via the PI3K-AKT-mediated MDM2-p53 axis Targeting host lipid flows: Exploring new antiviral and antibiotic strategies